Clinical Trial Update: BL3000 Compared to Pantogar® in the Treatment of Telogen Effluvium in Women. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing BL3000 to Pantogar in treating Telogen Effluvium in women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Telogen Effluvium

Drugs mentioned

• BL3000
• Pantogar

Snippet

Sponsor: Biolab Sanus Farmaceutica | Conditions: Telogen Effluvium | Phase 3 | Status: UNKNOWN